MedTrace Logo

Evaluation of the Potential Impact of Computerized Antimicrobial Stewardship

NCT04328090 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2473

Last updated 2022-03-09

No results posted yet for this study

Summary

This trial is an open-label, two-arm, cluster-randomized, controlled trial with cardiovascular surgical teams as the unit of randomization. Eligible teams with written consent are randomized to the intervention or control arm by random number generator. Computer-based, multicomponent intervention targeting on reduction of perioperative antimicrobial use will be delivered to teams in the intervention arm. Teams in the control arm will continue with usual clinical care.

Conditions

  • Antimicrobial Stewardship
  • Cardiovascular Surgeries
  • Computerized Decision Support System
  • Coronary Artery Disease
  • Valve Heart Disease

Interventions

OTHER

Computer based Antimicrobial stewardship (AMS) intervention system

1. Re-evaluation alerts and decision support for the duration of antimicrobial treatment. 2. Re-evaluation alerts and decision support for the choice of antimicrobial. 3. Quality control audit and feedback.

Sponsors & Collaborators

  • China National Center for Cardiovascular Diseases

    lead OTHER_GOV

Principal Investigators

  • Shengshou Hu, MD · Chinese Academy of Medical Sciences, Fuwai Hospital

  • Xin Yuan, PhD · Chinese Academy of Medical Sciences, Fuwai Hospital

  • Kai Chen, PhD · Chinese Academy of Medical Sciences, Fuwai Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-27
Primary Completion
2021-05-30
Completion
2021-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04328090 on ClinicalTrials.gov